Revenue Update on American Renal Associates Holdings(NYSE:ARA)

American Renal Associates Holdings(NYSE:ARA) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during After-hours on Aug 9, 2016. Company reported revenue of $185.57M. Analysts estimated a revenue of $177.91M. Earnings per share were $0.26. Analysts had estimated an EPS of $0.22.

In a different note, Barclays said it Initiates Coverage on American Renal Associates Holdings, according to a research note issued on May 16, 2016. The shares have been rated ‘Overweight’ by the firm. Goldman Sachs said it Initiates Coverage on American Renal Associates Holdings, according to a research note issued on May 16, 2016. The shares have been rated ‘Neutral’ by the firm. SunTrust Robinson Humphrey said it Initiates Coverage on American Renal Associates Holdings, according to a research note issued on May 16, 2016. The shares have been rated ‘Buy’ by the firm. Wells Fargo said it Initiates Coverage on American Renal Associates Holdings, according to a research note issued on May 16, 2016. The shares have been rated ‘Outperform’ by the firm.

Several Insider Transactions has been reported to the SEC. On Apr 27, 2016, Syed T Kamal (PRESIDENT) purchased 500 shares at $22.00 per share price.Also, On Apr 27, 2016, Michael Ray Costa (VP, GC AND SECRETARY) purchased 370 shares at $22.00 per share price.On Apr 27, 2016, Joseph A Carlucci (CEO) purchased 500 shares at $22.00 per share price, according to the Form-4 filing with the securities and exchange commission.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *